[1] |
ZHENG Senyuan, LIU Fang, HE Xiaolei, ZHANG Zhiqiang.
Effects of miR-130a on angiogenesis in exosomes of esophageal squamous cell carcinoma cells and its mechanism
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(1): 50-55.
|
[2] |
CHEN Li, LIN Guoxiang, CHEN Kaihua, SUN Yongchu, WAN Fangzhu, ZHU Xiaodong.
Effect of silencing
VEGF on the invasion and migration of radioresistant human nasopharyngeal
carcinoma cell line CNE-2R
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(6): 474-479.
|
[3] |
LIU Lu, LIU Lijuan, LI Yin, HUANG Xiaoxin, KANG Wei, WEI Bo, SU Danke, JIN Guanqiao.
Expression of ELAM-1 in nasopharyngeal carcinoma xenografts in nude mice and its rela-tionship with metastasis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(1): 58-62.
|
[4] |
Wang Xiangping,Zhan Yongzi,Mao Yan,Chen Hao,Liang Ting,Huang Changjie.
Effect of celecoxib on radiochemotherapy sensitivity of nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 393-396.
|
[5] |
Zhong Dani,Tan Xiaohong,Cen Hong,Huang Qiuju,Sun Jie,Liao Chengcheng, He Sha,Rong Chao.
Clinical observations of gemcitabine combined with vinorelbine as second-line treatment in patients with metastatic nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 295-298.
|
[6] |
Yu Xueting,Yang Bo,Wei Zheng,Huang Gaoming.
Factors influencing image T residue at the end of intensity-modulated radiotherapy for nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 221-225.
|
[7] |
Li Bo, Kang Min, Lu Ying, Yu Bin, Liao Xueyin, Bin Ying, Zhou Pingting, Yang Zhendong, Liu Kang, Li Jixi, Wang Rensheng.
Patterns of local or regional recurrence after intensity-modulated radiotherapy for nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 124-128.
|
[8] |
He Huocong,Su Ying,Lin Keyu,Zou Changyan,Chen Chao.
Effects of shRNA-mediated silencing of Annexin A2 on migration and invasion of radioresistant nasopharyngeal carcinoma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(4): 295-301.
|
[9] |
Meng Huiling,Zhu Xiaodong,Li Ling,Liang Zhongguo,Pan Xinbin,Zeng Fanyan,Qu Song.
Identification of novel serum biomarkers for recurrent nasopharyngeal carcinoma using TMT-based quantitative proteomic analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(3): 167-171.
|
[10] |
Lin Huan,Zhu Xiaodong,Chen Zetan, Li Ling,Qu Song,Zhao Wei,Su Fang,Wei Jingni,Liang Zhongguo,Mo Qiyan,Wu Jiangbo,Meng Huiling .
Effects of CD166 on radioresensitivity of nasopharyngeal carcinoma cell line CNE-2
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(1): 45-49.
|
[11] |
.
Optimizing construction of a nasopharyngeal cancer CNE-2R cell stably expressing XAF1
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(6): 349-353.
|
[12] |
Li Quanyi,Dai Xiangkun,Cai Boning,Chen Gaoxiang,Wang Jinyuan,Song Mingyong,Fang Chunfeng,Dou Chao.
Dosimetric comparison of helical tomotherapy and rapid arc therapy for patients with nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(4): 230-234.
|
[13] |
SUN Jie,CEN Hong,TAN Xiao-hong.
Analysis of VEGF and MVD expression in primary triple-negative breast cancer and non-triple-negative breast cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(4): 333-336.
|
[14] |
HUANG Xiao-peng,MA Hui,ZHU Xiao-dong,GE Lian-ying,QU Song,LI Ling,GUO Ya,ZHAO Wei,LI Dan-rong.
Establishment and dynamic in vivo imaging of a radioresistant,GFP-labelled xenograft tumor model of human nasopharyngeal carcinoma in mouse
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(4): 291-295.
|
[15] |
SHI Jin-ping,ZHANG Li-wen,TAN Yi-chang,TENG Jian-jian,XIE Qiu-ying.
Comparison of different beam arrangements in intensity-modulated radiation therapy to treat nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(2): 134-138.
|